⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14593777 | 0.85 | — | — | |
| SCHEMBL12055898 | 0.79 | — | — | |
| SCHEMBL1847508 | 0.78 | — | — | |
| SCHEMBL6044442 | 0.76 | — | — | |
| SCHEMBL10406707 | 0.72 | GPR84 (0.47) | — | |
| SCHEMBL7435821 | 0.72 | GPR84 (0.47) | — | |
| SCHEMBL11504238 | 0.72 | GPR84 (0.47) | — | |
| SCHEMBL9439003 | 0.72 | GPR84 (0.47) | — | |
| SCHEMBL87376 | 0.71 | — | — | |
| SCHEMBL14593778 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090118297-A1 | POLYMORPHS OF DASATINIB AND PROCESS FOR PREPARATION THEREOF | ASSIA CHEMICAL INDUSTRIES LTD. (IL) | 2009-05-07 | — | — | US | claimed |
| US-11833249-B2 | Rapidly disintegrating solid oral dosage forms containing dasatinib | XSPRAY PHARMA AB (SE) | 2023-12-05 | — | — | US | disclosed |
| US-11344500-B2 | Rapidly disintegrating solid oral dosage forms containing dasatinib | XSPRAY PHARMA AB (SE) | 2022-05-31 | — | — | US | disclosed |
| US-20210085609-A1 | RAPIDLY DISINTEGRATING SOLID ORAL DOSAGE FORMS CONTAINING DASATINIB | XSPRAY PHARMA AB (SE) | 2021-03-25 | — | — | US | disclosed |
| US-10894017-B1 | Rapidly disintegrating solid oral dosage forms containing dasatinib | XSPRAY PHARMA AB (SE) | 2021-01-19 | — | — | US | disclosed |
| US-10894018-B1 | Rapidly disintegrating solid oral dosage forms containing dasatinib | XSPRAY PHARMA AB (SE) | 2021-01-19 | — | — | US | disclosed |
| US-10874613-B1 | Rapidly disintegrating solid oral dosage forms containing dasatinib | XSPRAY PHARMA AB (SE) | 2020-12-29 | — | — | US | disclosed |
| US-10874614-B1 | Rapidly disintegrating solid oral dosage forms containing dasatinib | XSPRAY PHARMA AB (SE) | 2020-12-29 | — | — | US | disclosed |
| US-10869836-B1 | Rapidly disintegrating solid oral dosage forms containing dasatinib | XSPRAY PHARMA AB (SE) | 2020-12-22 | — | — | US | disclosed |
| US-10869837-B1 | Rapidly disintegrating solid oral dosage forms containing dasatinib | XSPRAY PHARMA AB (SE) | 2020-12-22 | — | — | US | disclosed |
| EP-2598147-A1 | N-METHYLFORMAMIDE SOLVATE OF DASATINIB | Ranbaxy Laboratories Limited (IN) | 2013-06-05 | — | — | EP | disclosed |
| EP-2537847-A1 | Polymorphs of dasatinib and process for preparation thereof | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 2012-12-26 | — | — | EP | disclosed |
| EP-2508523-A2 | Polymorphs of dasatinib and process for preparation thereof | Teva Pharmaceutical Industries Ltd. (IL) | 2012-10-10 | — | — | EP | disclosed |
| WO-2012014149-A1 | N-METHYLFORMAMIDE SOLVATE OF DASATINIB | RANBAXY LABORATORIES LIMITED (IN) | 2012-02-02 | — | — | WO | disclosed |
| US-8067423-B2 | Polymorphs of dasatinib isopropyl alcohol and process for preparation thereof | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2011-11-29 | — | — | US | disclosed |
| US-7973045-B2 | Anhydrous form of dasatinib and process for preparation thereof | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2011-07-05 | — | — | US | disclosed |
| US-20100256158-A1 | POLYMORPHS OF DASATINIB AND PROCESS FOR PREPARATION THEREOF | ASSIA CHEMICAL INDUSTRIES LTD. (IL) | 2010-10-07 | — | — | US | disclosed |
| EP-2207777-A2 | POLYMORPHS OF DASATINIB AND PROCESS FOR PREPARATION THEREOF | Teva Pharmaceutical Industries Ltd. (IL) | 2010-07-21 | — | — | EP | disclosed |
| US-20090118297-A1 | POLYMORPHS OF DASATINIB AND PROCESS FOR PREPARATION THEREOF | ASSIA CHEMICAL INDUSTRIES LTD. (IL) | 2009-05-07 | — | — | US | disclosed |
| WO-2009053854-A2 | POLYMORPHS OF DASATINIB AND PROCESS FOR PREPARATION THEREOF | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2009-04-30 | — | — | WO | disclosed |